teva mylan adapt challeng gener
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jul
estim jul
price data jul
rate updat jul
currenc amount express
methodolog valu compani
took fresh deep dive analysi teva
continu view compani moat
two controversi healthcar name batter
gener drug price pressur confluenc legal
matter concern high debt load market
backdrop made critic focu rapidli replenish
gener specialti pipelin aggress right size
infrastructur flex scale fend
intern competitor significantli lower cost
structur despit commod natur gener
need regulatori compliant cost-effect drug overal
expect compani trade base pipelin
progress opioid litig especi ohio abil
teva transpar activ
differenti focus specialti drug rel
complex manufactur gener fiscal
like trough year teva revenu new
specialti drug ajovi austedo off-set declin
blockbust specialti drug copaxon although
compani cost save initi continu launch
track well tweak fair valu estim
reflect slight shift cash flow time
also includ million litig settlement
teva fiscal expect total opioid litig
hover around billion estim level
manag allow compani gener
oper cash flow pay matur debt
like benefit near term pend
launch wixela gener advair gener copaxon
howev confid abil introduc
complex new therapi replenish pipelin beyond
anticip fiscal launch think weigh
margin previous expect result
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
regist netherland lead gener drugmak
roughli manufactur facil although compani
form compani posit second-largest gener
compani larg attribut acquisit matrix laboratori
gener busi germany-bas merck kgaa portfolio
gener specialti over-the-count activ
ingredi medicin
manufactur epipen treatment anaphylaxi acquir
merk kgaa transact
predominantli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
lower fair valu estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
